Curcumin ameliorates mitochondrial dysfunction associated with inhibition of gluconeogenesis in free fatty acid-mediated hepatic lipoapoptosis

International Journal of Molecular Medicine

Volumn 30, Issue 3, 2012, Pages 643-649

  Kuo, Jong Jen ^a,b   Chang, Hen Hong ^a,b,c   Tsai, Tung Hu ^a   Lee, Tzung Yan ^c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Curcumin; Lipoapoptosis; Mitochondrial dysfunction

Indexed keywords

ADENOSINE TRIPHOSPHATE; CURCUMIN; FATTY ACID; GLUCOSE 6 PHOSPHATASE; HIGH FREE FATTY ACID; MITOCHONDRIAL DNA; MITOCHONDRIAL TRANSCRIPTION FACTOR A; NUCLEAR RESPIRATORY FACTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BIOGENESIS; CELL DESTRUCTION; CELL PROTECTION; CELL SURVIVAL; DOWN REGULATION; ENZYME SYNTHESIS; GENE DOSAGE; GLUCONEOGENESIS; LIVER CELL; LIVER PROTECTION; MITOCHONDRIAL DYSFUNCTION; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT;

APOPTOSIS; CELL NUCLEUS; CURCUMIN; FATTY ACIDS, NONESTERIFIED; GLUCONEOGENESIS; GLUCOSE-6-PHOSPHATASE; HEPATOCYTES; LIPID METABOLISM; MITOCHONDRIA; NF-KAPPA B; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROTEIN TRANSPORT; REACTIVE OXYGEN SPECIES;

EID: 84865158452     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1020     Document Type: Article

References (31)

1. Feldstein AE, Canbay A, Guicciardi ME, Higuchi H, Bronk SF and Gores GJ: Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. J Hepatol 39: 978-983, 2003. (Pubitemid 37523769)
2. Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD and Gores GJ: Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125: 437-443, 2003. (Pubitemid 36929425)
3. Mantena SK, Vaughn DP, Andringa KK, et al: High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo. Biochem J 417: 183-193, 2009.
4. Rao MS and Reddy JK: PPARalpha in the pathogenesis of fatty liver disease. Hepatology 40: 783-786, 2004. (Pubitemid 39288108)
5. O'Connell MA and Rushworth SA: Curcumin: potential for hepatic fibrosis therapy. Br J Pharmacol 153: 403-405, 2008. (Pubitemid 351199013)
6. 4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol Pharmacol 73: 399-409, 2008.
7. Zheng S and Chen A: Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor. Am J Physiol Gastrointest Liver Physiol 290: G883-G893, 2006.
8. Tang Y, Zheng S and Chen A: Curcumin eliminates leptin's effects on hepatic stellate cell activation via interrupting leptin signaling. Endocrinology 150: 3011-3020, 2009.
9. Bharti AC, Takada Y and Aggarwal BB: Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis. J Immunol 172: 5940-5947, 2004. (Pubitemid 38621193)
10. Bachmeier BE, Mohrenz IV, Mirisola V, et al: Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB. Carcinogenesis 29: 779-789, 2008. (Pubitemid 351494166)
11. Wang SL, Li Y, Wen Y, Chen YF, LX Na, ST Li and Sun CH: Curcumin, a potential inhibitor of up-regulation of TNF-alpha and IL-6 induced by palmitate in 3T3-L1 adipocytes through NF-kappaB and JNK pathway. Biomed Environ Sci 22: 32-39, 2009.
12. Lee TY, Chen FY, Chang HH and Lin HC: The effect of capillarisin on glycochenodeoxycholic acid-induced apoptosis and heme oxygenase-1 in rat primary hepatocytes. Mol Cell Biochem 325: 53-59, 2009.
13. Kohli R, Pan X, Malladi P, Wainwright MS and Whitington PF: Mitochondrial reactive oxygen species signal hepatocyte steatosis by regulating the phosphatidylinositol 3-kinase cell survival pathway. J Biol Chem 282: 21327-21336, 2007. (Pubitemid 47099964)
14. Folch J, Lees M and Sloane Stanley GH: A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509, 1957.
15. Tedesco L, Valerio A, Cervino C, et al: Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes. Diabetes 57: 2028-2036, 2008.
16. Tedesco L, Valerio A, Dossena M, et al: Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways. Diabetes 59: 2826-2836, 2010.
17. González R, Ferrín G, Hidalgo AB, et al: N-acetylcysteine, coenzyme Q10 and superoxide dismutase mimetic prevent mitochondrial cell dysfunction and cell death induced by d-galactosamine in primary culture of human hepatocytes. Chem Biol Interact 181: 95-106, 2009.
18. Schaffer JE: Lipotoxicity: when tissues overeat. Curr Opin Lipidol 14: 281-287, 2003.
19. Wei Y, Rector RS, Thyfault JP and Ibdah JA: Nonalcoholic fatty liver disease and mitochondrial dysfunction. World J Gastroenterol 14: 193-199, 2008. (Pubitemid 351314298)
20. Hirsch T, Marzo I and Kroemer G: Role of the mitochondrial permeability transition pore in apoptosis. Biosci Rep 17: 67-76, 1997. (Pubitemid 27267593)
21. Li L, Chen L, Hu L, et al: Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice. Hepatology 54: 1620-1630, 2011.
22. Liu SF and Malik AB: NF-kappa B activation as a pathological mechanism of septic shock and inflammation. Am J Physiol Lung Cell Mol Physiol 290: L622-L645, 2006. (Pubitemid 43738989)
23. Rafiee P, Binion DG, Wellner M, et al: Modulatory effect of curcumin on survival of irradiated human intestinal microvascular endothelial cells: role of Akt/mTOR and NF-kappaB. Am J Physiol Gastrointest Liver Physiol 298: G865-G877, 2010.
24. Pessayre D and Fromenty B: NASH: a mitochondrial disease. J Hepatol 42: 928-940, 2005. (Pubitemid 40693212)
25. Demeilliers C, Maisonneuve C, Grodet A, et al: Impaired adaptive resynthesis and prolonged depletion of hepatic mitochondrial DNA after repeated alcohol binges in mice. Gastroenterology 123: 1278-1290, 2002.
26. Pérez-Carreras M, Del Hoyo P, Martín MA, et al: Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 38: 999-1007, 2003. (Pubitemid 37221683)
27. Videla LA, Rodrigo R, Araya J and Poniachik J: Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease. Trends Mol Med 12: 555-558, 2006. (Pubitemid 44780196)
28. Gallagher EJ, Leroith D and Karnieli E: Insulin resistance in obesity as the underlying cause for the metabolic syndrome. Mt Sinai J Med 77: 511-523, 2010.
29. Lin J, Wu H, Tarr PT, et al: Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 15: 797-801, 2002.
30. Weisberg SP, Leibel R and Tortoriello DV: Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology 149: 3549-3558, 2008. (Pubitemid 351919581)
31. Kim T, Davis J, Zhang AJ, He X and Mathews ST: Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells. Biochem Biophys Res Commun 388: 377-382, 2009.